Hemodynamic effects of cannabinoids: Coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors

Jens A. Wagner, Zoltán Járai, Sándor Bátkai, George Kunos

Research output: Contribution to journalArticle

149 Citations (Scopus)

Abstract

Activation of peripheral cannabinoid CB1 receptors elicits hypotension. Using the radioactive microsphere technique, we examined the effects of cannabinoids on systemic hemodynamics in anesthetized rats. The potent cannabinoid CB1 receptor agonist HU-210 ({ - }-11-OH-Δ9 tetrahydrocannabinol dimethylheptyl, 10 μg/kg i.v.) reduced mean blood pressure by 57 ± 5 mm Hg by decreasing cardiac index from 37 ± 1 to 23 ± 2 ml/min/100 g (P < 0.05) without significantly affecting systemic vascular resistance index. HU-210 elicited a similar decrease in blood pressure following ganglionic blockade and vasopressin infusion. The endogenous cannabinoid anandamide (arachidonyl ethanolamide, 4 mg/kg i.v.) decreased blood pressure by 40 ± 7 mm Hg by reducing systemic vascular resistance index from 3.3 ± 0.1 to 2.3 ± 0.1 mm Hg min/ml/100 g (P < 0.05), leaving cardiac index and stroke volume index unchanged. HU-210, anandamide, and its metabolically stable analog, R-methanandamide, lowered vascular resistance primarily in the coronaries and the brain. These vasodilator effects remained unchanged when autoregulation was prevented by maintaining blood pressure through volume replacement, but were prevented by pretreatment with the cannabinoid CB1 receptor antagonist SR141716A (N-{piperidin-1-yl}-5-{4-chlorophenyl}-1-{2,4-dichlorophenyl}-4-methyl-1H- pyrazole-3-carboxamide HCl; 3 mg/kg i.v.). Only anandamide and R-methanandamide were vasodilators in the mesentery. We conclude that cannabinoids elicit profound coronary and cerebral vasodilation in vivo by direct activation of vascular cannabinoid CB1 receptors, rather than via autoregulation, a decrease in sympathetic tone or, in the case of anandamide, the action of a non-cannabinoid metabolite. Differences between the hemodynamic profile of various cannabinoids may reflect quantitative differences in cannabinoid CB1 receptor expression in different tissues and/or the involvement of as-yet-unidentified receptors.

Original languageEnglish
Pages (from-to)203-210
Number of pages8
JournalEuropean Journal of Pharmacology
Volume423
Issue number2-3
DOIs
Publication statusPublished - Jul 6 2001

Keywords

  • Anandamide
  • Cannabinoid CB receptor
  • HU-210
  • Microsphere
  • R-methanandamide

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Hemodynamic effects of cannabinoids: Coronary and cerebral vasodilation mediated by cannabinoid CB<sub>1</sub> receptors'. Together they form a unique fingerprint.

  • Cite this